Asston Pharmaceuticals Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 3,000 shares,. Its Average Traded Price (ATP) is ₹97.30, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1000 @ ₹97.40.
Asston Pharmaceuticals has an upper circuit limit of ₹102.37 and a lower circuit limit of ₹92.63. The total value traded stands at ₹2.92 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1000. Asston Pharmaceuticals also offers a dividend yield of 0%.
Asston Pharmaceuticals Share Price Chart
Asston Pharmaceuticals Share Key Metrics
Volume
3000.00
Market Cap
106.39 CR
LTQ@LTP
1000@97.40
ATP
97.3
Var Margin
100 %
Circuit Range
92.63-102.37
Delivery %
0 %
Value
2.92 L
ASM/GSM
No
Market Lot
1000
Asston Pharmaceuticals Resistance and Support
Pivot 97.75
Resistance
First Resistance
98
Second Resistance
98.5
Third Resistance
98.75
Support
First Support
97.25
Second Support
97
Third Support
96.5
Asston Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-04 | A.G.M. |
| 2026-07-02 | Preferential Issue of shares & Others |
| 2026-05-29 | Audited Results |
| 2026-03-30 | Notice of EGM & Others |
| 2026-02-07 | Raising of Funds |
| 2026-01-05 | Others |
| 2025-11-14 | Half Yearly Results |
| 2025-10-16 | Others |
| 2025-08-25 | A.G.M. |
Asston Pharmaceuticals News
Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Allotment
Asston Pharmaceuticals' Board approved the allotment of 24.10 lakh equity shares at Rs. 115 per share, including a premium of Rs. 105, via a preferential issue. This allotment raises the company's paid-up equity share capital to Rs. 10.92 crore, comprising 1.09 crore shares.
Sep 05 2026 13:13:25
Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Allotment Of 24,10,431 Equity Shares Via Preferential Allotment
Asston Pharmaceuticals' board approved the allotment of 24.10 lakh equity shares through a preferential issue. This fundraise, at an issue price of Rs.115 per share, will inject Rs.27.72 crore into the company and increase its paid-up share capital.
Sep 05 2026 13:09:06
Asston Pharmaceuticals Ltd - 544445 - Fixing Record Date
Asston Pharma sets September 22, 2026, as the record date for e-voting eligibility. This applies to shareholders participating in the 7th Annual General Meeting.
Sep 04 2026 19:44:36
Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Change in Management
Asston Pharmaceuticals board re-appointed Mr. Ashish Sakalkar as Managing Director, subject to shareholder approval. The board also approved increases in remuneration for Mr. Sakalkar, CEO Mrs. Saili More, and Non-Executive Director Mr. Sachin Badakh.
Sep 04 2026 19:35:06
Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Out Come Of The Board Meeting
Asston Pharmaceuticals board approved the appointment of M/s Yash A. Jain & Associates as Internal Auditor and M/s Panchal S K & Associates as Statutory Auditors. The board also re-appointed Ashish Sakalkar as Managing Director and proposed remuneration increases for key executives, subject to shareholder approval.
Sep 04 2026 19:31:13
Asston Pharmaceuticals Ltd - 544445 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Prakruti R Pali, a non-promoter, increased shareholding in Asston Pharmaceuticals by acquiring 1,64,000 shares in the open market. This raised her stake from 5.33% to 7.26%.
Sep 02 2026 11:36:50
Asston Pharmaceuticals Management
| Name | Position |
|---|---|
| Ashish Narayan Sakalkar | Managing Director |
| Saili Jayaram More | Whole Time Director & Chief Executive Officer |
Asston Pharmaceuticals Similar Stocks
Raaj Medisafe India Ltd.
98.97
3.87 (4.07%)
Makers Laboratories Ltd.
178.25
-7.20 (3.88%)
Mercury Laboratories Ltd.
748.00
-2.00 (0.27%)
Himalaya Nutravedics India Ltd.
122.60
5.80 (4.97%)
Bharat Immunologicals & Biologicals Corporation Ltd.
8.18
-0.88 (9.71%)
Pharmaids Pharmaceuticals Ltd.
30.15
0.75 (2.55%)
Modern Diagnostic & Research Centre Ltd.
71.90
-1.35 (1.84%)
Concord Drugs Ltd.
75.70
1.17 (1.57%)
Asston Pharmaceuticals FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in APL
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC